OMERS Administration Corp’s Albany Molecular Research Inc AMRI Stock Holding History

OMERS Administration Corp’s Portfolio AMRI Stock Details AMRI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q3	–	Sell	-143,900	Closed	-$3.12M	–	558
2017 Q2	$3.12M	Buy	+143,900	New	+$2.61M	0.04%	108

Other funds holding AMRI

Ancora Advisors Cleveland, Ohio $4.7B AUM 19.05% 1-Year Est. Return

DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return

OMERS Administration Corp's AMRI Position: Q3 2017 in Review

OMERS Administration Corp sold out of Albany Molecular Research Inc (AMRI) in Q3 2017, closing a stake of 143,900 shares — an estimated $3.12M sold.

OMERS Administration Corp first reported a position in AMRI in Q2 2017 and held it in 1 quarter. The position peaked at $3.12M in Q2 2017. 2 funds tracked by Wall St. Rank hold AMRI as of Q3 2017.

OMERS Administration Corp reported no remaining Albany Molecular Research Inc position as of Q3 2017 after selling out during the quarter.
OMERS Administration Corp sold 143,900 Albany Molecular Research Inc shares in Q3 2017, an estimated $3.12M.
OMERS Administration Corp first reported a position in Albany Molecular Research Inc in Q2 2017 and held it in 1 quarter.
OMERS Administration Corp's Albany Molecular Research Inc position peaked at $3.12M in Q2 2017.
2 funds tracked by Wall St. Rank held Albany Molecular Research Inc as of Q3 2017.

Based on OMERS Administration Corp's 13F filing for Q3 2017, filed 13 Nov 2017.